Inhibiting SagA enzyme restores vancomycin effectiveness against resistant bacteria
Genetic or pharmacological inactivation of SagA impairs peptidoglycan remodelling in vancomycin-resistant Enterococcus faecium and restores susceptibility to the antibiotic in both ex vivo and in vivo settings.
22 JUL
· 3 min read
